cytarabine has been researched along with Benign Supratentorial Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, Y; Ikemura, M; Kurokawa, M; Miyawaki, S; Nakatomi, H; Saito, N; Satou, M; Takayanagi, S; Tanaka, R; Tanaka, S; Taoka, K; Toyama, K | 1 |
| Deckert, M; Montesinos-Rongen, M; Pels, H; Schaller, C; Schlegel, U; Van Roost, D; Wiestler, OD | 1 |
| Guenther, PP; Huebner, A; Neumeister, V; Parwaresch, R; Sobottka, SB; Todt, H; Weissbach, G | 1 |
| Bamberg, M; Dieckmann, K; Kortmann, RD; Kühl, J; Meisner, C; Pietsch, T; Timmermann, B | 1 |
1 trial(s) available for cytarabine and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Male; Methotrexate; Neoplasm Recurrence, Local; Neuroectodermal Tumors; Radiotherapy Dosage; Supratentorial Neoplasms; Survival Rate; Treatment Outcome; Vincristine | 2002 |
3 other study(ies) available for cytarabine and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Small Cell Variant of Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma of the Dura Mimicking Tentorial Meningioma.
Topics: Adult; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Cytarabine; Diagnosis, Differential; Etoposide; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Meningeal Neoplasms; Meningioma; Methotrexate; Supratentorial Neoplasms | 2020 |
Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Base Sequence; Breast Neoplasms; Clone Cells; Combined Modality Therapy; Cytarabine; DNA, Neoplasm; Embryonal Carcinoma Stem Cells; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Genes, Immunoglobulin; Germinal Center; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Methotrexate; Molecular Sequence Data; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neoplastic Stem Cells; Parietal Lobe; Remission Induction; Sequence Alignment; Sequence Homology, Nucleic Acid; Supratentorial Neoplasms; Temporal Lobe | 2004 |
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Injections, Spinal; Interferon alpha-2; Interferon-alpha; Mast-Cell Sarcoma; Nausea; Neoplasm Recurrence, Local; Palliative Care; Papilledema; Parietal Lobe; Prednisolone; Radioisotope Teletherapy; Recombinant Proteins; Remission Induction; Supratentorial Neoplasms; Temporal Lobe; Treatment Failure; Vomiting | 2001 |